Snowden Capital Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.25M Sell
8,789
-3,634
-29% -$964K 0.1% 210
2026
Q1
$1.36M Buy
12,423
+6,681
+116% +$952K 0.04% 435
2025
Q4
$955K Sell
5,742
-3,241
-36% -$542K 0.02% 545
2025
Q3
$1.76M Sell
8,983
-496
-5% -$81.6K 0.05% 353
2025
Q2
$857K Sell
9,479
-4,945
-34% -$391K 0.03% 573
2025
Q1
$861K Buy
14,424
+5,870
+69% +$543K 0.03% 562
2024
Q4
$1.13M Buy
+8,554
New +$803K 0.04% 470

Other funds holding ALAB

Snowden Capital Advisors's ALAB Position: Q2 2026 in Review

Snowden Capital Advisors reduced its Astera Labs (ALAB) stake by 29% in Q2 2026, selling an estimated $964K and leaving 8,789 shares worth $4.25M. The position accounts for 0.1% of the portfolio, ranked #210.

Snowden Capital Advisors first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Snowden Capital Advisors held 8,789 shares of Astera Labs worth $4.25M as of Q2 2026.
  • Snowden Capital Advisors sold 3,634 Astera Labs shares in Q2 2026, an estimated $964K.
  • Astera Labs made up 0.1% of Snowden Capital Advisors's portfolio in Q2 2026, its #210 holding.
  • Snowden Capital Advisors first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Snowden Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.